+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Strongbridge Biopharma plc (SBBP) - Financial and Strategic SWOT Analysis Review

  • ID: 4278473
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.


Strongbridge Biopharma plc (Strongbridge), formerly Cortendo plc, is a commercial-stage biopharmaceutical company that develops and commercializes therapies for rare diseases. The company’s marketed product, KEVEYIS (dichlorphenamide), is indicated for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis, a genetic neuromuscular disorder. Strongbridge acquired the US rights to KEVEYIS (dichlorphenamide) from a subsidiary of Taro Pharmaceutical Industries Ltd. KEVEYIS holds orphan drug designation in the US. Its pipeline products include COR-003 (levoketoconazole), a cortisol synthesis inhibitor for the treatment of endogenous Cushing’s syndrome; and COR-005, a novel somatostatin analog for the treatment of acromegaly, with potential use in Cushing's syndrome and neuroendocrine tumors. Strongbridge’s primary focus is on building franchise around rare endocrine disorders including product candidates for the treatment of endogenous Cushing’s syndrome and acromegaly. Strongbridge is headquartered in Trevose, Pennsylvania, the US.

Strongbridge Biopharma plc Key Recent Developments

Nov 14, 2017: Strongbridge Biopharma Provides Corporate Update and Reports Third Quarter 2017 Financial Results
Sep 25, 2017: Strongbridge Biopharma Launches the Uncovering Periodic Paralysis Genetic Testing Program
Aug 07, 2017: Strongbridge Biopharma Provides Updates on KEVEYIS Launch and Recent Business Highlights, and Reports Second Quarter 2017 Financial Results
May 16, 2017: Strongbridge Biopharma Provides Corporate Update and Reports First Quarter 2017 Financial Results
Mar 27, 2017: Strongbridge Biopharma Provides Corporate Update and Reports Full-Year 2016 Financial Results

This comprehensive SWOT profile of Strongbridge Biopharma plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Strongbridge Biopharma plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
Section 1 - About the Company
  • Strongbridge Biopharma plc - Key Information
  • Strongbridge Biopharma plc - Overview
  • Strongbridge Biopharma plc - Key Employees
  • Strongbridge Biopharma plc - Key Employee Biographies
  • Strongbridge Biopharma plc - Key Operational Heads
  • Strongbridge Biopharma plc - Major Products and Services
  • Strongbridge Biopharma plc - History
  • Strongbridge Biopharma plc - Company Statement
  • Strongbridge Biopharma plc - Locations And Subsidiaries
  • Strongbridge Biopharma plc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Strongbridge Biopharma plc - Business Description
  • Strongbridge Biopharma plc - Corporate Strategy
  • Strongbridge Biopharma plc - SWOT Analysis
  • SWOT Analysis - Overview
  • Strongbridge Biopharma plc - Strengths
  • Strongbridge Biopharma plc - Weaknesses
  • Strongbridge Biopharma plc - Opportunities
  • Strongbridge Biopharma plc - Threats
  • Strongbridge Biopharma plc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Strongbridge Biopharma plc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Strongbridge Biopharma plc, Key Information
  • Strongbridge Biopharma plc, Key Ratios
  • Strongbridge Biopharma plc, Share Data
  • Strongbridge Biopharma plc, Major Products and Services
  • Strongbridge Biopharma plc, History
  • Strongbridge Biopharma plc, Key Employees
  • Strongbridge Biopharma plc, Key Employee Biographies
  • Strongbridge Biopharma plc, Key Operational Heads
  • Strongbridge Biopharma plc, Other Locations
  • Strongbridge Biopharma plc, Subsidiaries
  • Strongbridge Biopharma plc, Key Manufacturing facilities
  • Strongbridge Biopharma plc, Key Competitors
  • Strongbridge Biopharma plc, SWOT Analysis
  • Strongbridge Biopharma plc, Ratios based on current share price
  • Strongbridge Biopharma plc, Annual Ratios
  • Strongbridge Biopharma plc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Strongbridge Biopharma plc, Performance Chart
  • Strongbridge Biopharma plc, Ratio Charts
Note: Product cover images may vary from those shown